Evaluation of the inhibitory effects of telmisartan on drug-induced renin-angiotensin-aldosterone system activation in normal dogs
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Journal of Veterinary Cardiology
- Vol. 20 (5) , 376-383
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Treatment of dogs with compensated myxomatous mitral valve disease with spironolactone—a pilot studyJournal of Veterinary Cardiology, 2017
- Aldosterone breakthrough in dogs with naturally occurring myxomatous mitral valve diseaseJournal of Veterinary Cardiology, 2017
- Associations between N-terminal procollagen type III, fibrosis and echocardiographic indices in dogs that died due to myxomatous mitral valve diseaseJournal of Veterinary Cardiology, 2014
- Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trialThe Lancet, 2008
- Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathyKidney International, 2008
- The incidence and implications of aldosterone breakthroughNature Clinical Practice Nephrology, 2007
- Aldosterone escape during blockade of the renin?angiotensin?aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rateDiabetologia, 2004
- Neurohormonal and clinical responses to high- versus low-dose enalapril therapy in chronic heart failureJACC, 2002
- The effect of benazepril on survival times and clinical signs of dogs with congestive heart failure: Results of a multicenter, prospective, randomized, double-blinded, placebo-controlled, long-term clinical trialJournal of Veterinary Cardiology, 1999
- Myocardial fibrosis and pathologic hypertrophy in the rat with renovascular hypertensionThe American Journal of Cardiology, 1990